London Daily

Focus on the big picture.
Sunday, Mar 22, 2026

Oxford Covid vaccine could be approved 'just after Christmas'

Oxford Covid vaccine could be approved 'just after Christmas'

The coronavirus vaccine being developed by Oxford University and AstraZeneca could be approved shortly after Christmas, a medical scientist has said.


Professor Sir John Bell said he expects the Medicines and Healthcare products Regulatory Agency (MRHA) to sign off its approval of the jab ‘pretty shortly’.

Sir John, Oxford University’s regius professor of medicine, told BBC Radio 4’s Today programme: ‘They got data quite a long time ago but that was the first set of data. They receive multiple sets of data.

‘So we are getting to be about prime time now, I would expect some news pretty shortly. I doubt we’ll make Christmas now, but just after Christmas I would expect. I have no concerns whatsoever that the data looks better than ever.’

His comments came as former prime minister Tony Blair called for major policy shifts in the rollout of vaccines, concentrating on giving more people a single dose with greater flexibility in who receives a jab.

Approval of the Oxford vaccine would be a major boost to efforts to control Covid-19 because it is easier to distribute than the Pfizer/BioNTech jab currently being used in the UK.


Approval from regulators is expected shortly after Christmas


The Government has ordered 100 million doses of the Oxford/AstraZeneca vaccine, with around 40 million available by the end of March.

Health Secretary Matt Hancock told a Downing Street press conference that the Oxford/AstraZeneca team has now submitted full data to the regulator for approval.

He said: ‘This is the next step towards a decision on the deployment of the vaccine which is already being manufactured, including here in the UK.’


The Government has ordered 100 million doses of the Oxford/AstraZeneca vaccine


Mr Blair told Today ‘the reality is we are now in severe lockdown until vaccination’ and so it should be a priority to give as many people as possible some protection.

While ideally people should received the required two doses, the question is: ‘Does the first dose give you substantial immunity, and by that I mean over 50% effectiveness?

‘If it does, there is a very strong case for not, as it were, holding back doses of the vaccine.’


A volunteer is administered the coronavirus vaccine developed by AstraZeneca and Oxford University


For example ‘if, in January, AstraZeneca is delivering you 10 or 20 million doses of the vaccine, you vaccinate 10 or 20 million people’.

Mr Blair went on: ‘You should get more vaccine coming on stream by the time you are ready for the second dose and that first dose can give you substantial immunity.’

The former premier also criticised the ‘somewhat inflexible “by age” structure’ used to determine who receives the jab.


A vial of coronavirus vaccine developed by AstraZeneca and Oxford University


Experts at the Joint Committee on Vaccination and Immunisation have drawn up a priority list based on clinical need.

But Mr Blair, who does not have a medical background, said ‘there is a strong case for saying you have got to focus also on the people spreading the disease, not simply the most vulnerable’.

Communities Secretary Robert Jenrick told Today that the Government is focusing on getting as many people as possible to receive the first dose of the Pfizer vaccine.

He said: ‘At the moment the priority is just to ensure that as many people as possible get the first shot of the vaccine.

‘Remember, the second shot has to be done, depending on what the vaccine is, 21 or 28 days later and so we still haven’t reached that point with the first people who were vaccinated.’

Asked whether the Government would consider dropping the second shot, Mr Jenrick said: ‘The strategy will always be kept under review but the priority today is to ensure that as many people as possible are given the first shot of the vaccine; that is what is happening.’

Newsletter

Related Articles

0:00
0:00
Close
Meghan Markle’s Possible UK Return Sparks Renewed Attention on Sussex Role
Starmer Convenes Urgent Talks on Cost-of-Living Pressures Linked to Iran Conflict
Starmer Convenes Urgent Talks on Cost-of-Living Pressures Linked to Iran Conflict
UK Investors Eye Bargain Shares Ahead of ISA Deadline Amid Market Volatility
UK Investors Eye Bargain Shares Ahead of ISA Deadline Amid Market Volatility
Northern Lights Expected Over UK Skies Tonight Amid Strong Solar Activity
UK Condemns Iran Missile Strike and Warns Against Threats to British Personnel
UK Warns of Global Flight Disruptions as Iran Conflict Escalates Under Trump’s Leadership
UK Condemns Iran After Missile Strike Targets Strategic Diego Garcia Base
Deadly Meningitis Outbreak in UK Reinforces Urgency of Vaccination Campaigns
Iran Launches Long-Range Missile Strike on Remote US-UK Base, Signaling Expanded Reach
Iran Launches Long-Range Missile Strike on Remote US-UK Base, Signaling Expanded Reach
UK Rules Out Cyprus Base Role in Joint US Self-Defence Framework
UK Ends Hereditary Peerage Rights in Parliament in Historic Constitutional Reform
Lord Walney Warns of Expanding Iranian Influence Networks Within the United Kingdom
Iranian National Among Two Arrested After Attempt to Access UK Nuclear Submarine Base
Deregulation, Artificial Intelligence, and Fraud Laws Reshape UK Financial Services Landscape
UK Considers Lower Speed Limits to Reduce Fuel Use Amid Escalating Energy Crisis
UK Borrowing Costs Surge to Post-Crisis High as Markets React to Inflation and War Risks
UK Government Prepares Emergency Economic Measures as Iran Conflict Fuels Financial Risks
Meningitis B Outbreak in the UK Raises Urgent Health Warnings as Cases Surge
Iran Issues Stark Warning to Britain Over US Base Access Amid Expanding Conflict
United Kingdom Authorizes US Strikes from British Bases as Iran Threatens Key Shipping Routes
Reform UK Suspends Scottish Candidate Following Financial Misconduct Allegations
Apple issues an unusual warning: this is how your iPhone can be hacked without you doing anything
UK and Nigeria Reach Agreement to Accelerate Return of Irregular Migrants
UK Sets New Aid Priorities Following Significant Budget Reductions
Cyprus President Urges Open Dialogue Over Future of British Sovereign Base Areas
Cyprus President Urges Open Dialogue Over Future of British Sovereign Base Areas
UK Plans 50% Steel Tariffs in Bold Move to Protect Domestic Industry
Iran Conflict Sends Shockwaves Through UK Economy as Energy Costs and Trade Risks Surge
UK Health Officials Warn Kent Meningitis Outbreak Still Active as Cases Continue to Rise
UK Climate Progress Faces Scrutiny Over Reliance on Carbon Accounting Methods
UK Deploys Advisers to United States to Shape Plan for Reopening Strait of Hormuz
Amazon Bets on AI-Driven Alexa Upgrade to Revive UK Smart Speaker Market
UK Abortion Law Changes Spark Strong Response from Church Leaders and Pro-Life Advocates
UK Abortion Law Changes Spark Strong Response from Church Leaders and Pro-Life Advocates
GB News Faces Regulatory Complaints Over On-Air Remarks on ‘Genocide’ Claims
UK Signals Expanded Support for Gulf Allies as Iranian Attacks Intensify Regional Threats
UK VAT Decision Opens Path for Potential Refunds to U.S. Biopharma Firms
UK and Canada Advance ‘Middle Power’ Strategy to Shape Global Influence Beyond Superpowers
Google Explores AI Opt-Out Features in Search to Address UK Regulatory Concerns
Google Explores AI Opt-Out Features in Search to Address UK Regulatory Concerns
UK Fuel Prices Poised to Surge as Global Tensions Drive Oil Market Volatility
UK Fuel Prices Poised to Surge as Global Tensions Drive Oil Market Volatility
UK Holds Back on Hormuz Escort Mission While Continuing Talks with Allies
TrumpRx Pricing Platform Faces Scrutiny as Some Medicines Remain Costlier Than in the UK
UK, Netherlands and Finland Explore Joint Defence Investment Bank to Boost Military Capability
Deadly Meningitis Outbreak in Kent Raises Alarm as Cases Surge and Emergency Response Expands
UK Security Adviser Viewed US-Iran Nuclear Deal as Within Reach Before Sudden Escalation
×